Globalbio Issue #120 has been released!

In this cover story, we explore Taiwan’s groundbreaking journey in rare disease innovation.

Twenty years after the enactment of Taiwan's Rare Disease and Orphan Drug Act, the country now ranks 5th in the world in providing legal protection for rare diseases. Despite Taiwan's advancements in the industry, clinical trials still lag behind those in the U.S and Europe.

With over 120 physicians leading the charge, learn how their passion is driving innovation in rare disease diagnosis and treatment. Is Taiwan on the verge of a new era in rare disease therapy development?

Read more in the latest issue! 

http://bit.ly/v120cover